While not yet FDA-approved for liver conditions, these agents improve metabolic parameters that influence hepatic health
10 As shown in FIGURE 3 , exenatide normalizes blood glucose levels by reducing fasting and postprandial glucose concentrations through a variety of mechanisms, including enhanced glucose-dependent insulin secretion, regulation of glucagon secretion, delayed gastric emptying, and decreased food intake due to centrally mediated effects on satiety
Though these findings stem from overseas imaging networks, they carry significant implications for patients and healthcare professionals
Bremelanotide is derived from the peptide hormone, melanotan II
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription